Læknablaðið - 15.04.2007, Síða 32

YFIRLITSGREIN / NÝRNAFRUMUKRABBAMEIN
3. Jónasson JG, Tryggvadóttir L. Cancer in Iceland. The 50th
Anniversary of The Icelandic Cancer Registry. Reykjavik:
Icelandic Cancer Society, 2004.
4. Guðbjartsson T, Einarsson GV, Jacobsen E, Magnússon J.
Krabbamein í nýmaskjóðu og þvagleiðurum. Afturskyggn
klínísk rannsókn. Læknablaðið 1994; 80:115-23.
5. Einarsson I, Guðbjartsson T, Einarsson GV, Jóhannsson
JH, Jónmundsson GK, Bjarnason G. Wilmsæxli á íslandi.
Afturskyggn rannsókn tímabilið 1961-1995. Læknablaðið 1998;
84:118-24.
6. Þórhallsson P, Tulinius H. Tlimours in Iceland. 3. Malignant
tumours of kidney. A histological classification. Acta Pathol
Microbiol Scand [A] 1981;89:403-10.
7. Guðbjartsson T, Gíslason T. Spontaneous regression of brain
metastasis secondary to renal cell carcinoma. Scand J Urol
Nephrol 1995;29:215-7.
8. Guðbjartsson T, Einarsson GV, Magnússon J. A population-
based analysis of survival and incidental diagnosing of renal
cell carcinoma patients in Iceland, 1971-1990. Scand J Urol
Nephrol 1996;30:451-5.
9. Guðbjartsson T, Harðarson S, Pétursdóttir V, Thoroddsen
Á, Magnússon J, Einarsson GV. Histological subtyping and
nuclear grading of renal cell carcinoma and their implications
for survival: a retrospective nation-wide study of 629 patients.
Eur Urol 2005; 48:593-600.
10. Guðbjartsson T, Harðarson S, Pétursdóttir V, Thoroddsen
Á, Magnússon J, Einarsson GV. Renal oncocytoma: a
clinicopathological analysis of 45 consecutive cases. BJU Int
2005;96:1275-9.
11. Guðbjartsson T, Jónasdóttir TJ, Thoroddsen Á, Einarsson
GV, Jónsdóttir GM, Kristjánsson K, et al. A population-based
familial aggregation analysis indicates genetic contribution in
a majority of renal cell carcinomas. Int J Cancer 2002; 100:476-
9.
12. Guðbjartsson T, Thoroddsen Á, Pétursdóttir V, Harðarson S,
Magnússon J, Einarsson GV. Effect of incidental detection
for survival of patients with renal cell carcinoma: results of
population-based study of 701 patients. Urology 2005; 66:1186-
9L
13. Guðbjartsson T, Thoroddsen Á, Gíslason T, Agnarsson
BA, Magnússon K, Geirsson G, et al. Sjálfkrafa hvarf á
meinvörpum nýmafrumukrabbameins í heila og fleiðruholi.
Tvö sjúkratilfelli. Læknablaðið 2002; 88:829-31.
14. Thoroddsen Á, Guðbjartsson T, Geirsson G, Agnarsson BA,
Magnússon K. Spontaneous regression of pleural metastases
after nephrectomy for renal cell carcinoma--a histologically
verified case with nine-year follow-up. Scand J Urol Nephrol
2002;36:396-8.
15. Thoroddsen Á, Guðbjartsson T, Jónsson E, Gíslason T,
Einarsson GV. Operative mortality after nephrectomy for
renal cell carcinoma. Scand J Urol Nephrol 2003; 37:507-11.
16. Ferlay J, Bray P, Pisani P, Parkin D. GLOBOCAN 2000: Cancer
Incidence, Mortality and Prevalence Worldwide. Version 1.0.
IARC CancerBase No.5. Lyon: IARCPress, 2001.
17 Guðbjartsson T. Renal Cell Carcinoma in Iceland: Incidence,
prognosis, inheritance and treatment. University of Iceland,
Reykjavik 2005.
18. Mathew A, Devesa SS, Fraumeni JF Jr., Chow WH. Global
increases in kidney cancer incidence, 1973-1992. Eur J Cancer
Prev 2002;11:171-8.
19. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising
incidence of renal cell cancer in the United States. JAMA 1999;
281:1628-31.
20. Guðbjartsson T, Einarsson GV, Magnússon J. Nýrnafrumu-
krabbamein eru óvenjualgeng á íslandi. Heilbrigðismál 1995;
4:27-8.
21. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics,
1999. CA Cancer J Clin 1999; 49:8-31,1.
22. Thoroddsen Á, Harðarson S, Pétursdóttir V, Magnússon J,
Einarsson GV, Guðbjartsson T. Renal cell carcinoma in young
compared to older patients. Comparison of clinicopathological
riskfactors and survival. Scand J Urol Nephrol (in press) 2007.
23 Dhote R, Pellicer-Coeuret M, Thiounn N, Debre B, Vidal-
Trecan G. Risk factors for adult renal cell carcinoma: a
systematic review and implications for prevention. BJU Int
2000; 86:20-7.
24. Lindblad P. Epidemiology of renal cell carcinoma. Scand J
Surg 2004; 93:88-96.
25. Parker AS, Cerhan JR, Janney CA, Lynch CF, Cantor KP.
Smoking cessation and renal cell carcinoma. Ann Epidemiol
2003; 13:245-51.
26. Liehr JG. Hormone-associated cancer: mechanistic similarities
between human breast cancer and estrogen-induced kidney
carcinogenesis in hamsters. Environ Health Perspect 1997; 105
Suppl 3:565-9.
27. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti
G, Lowenfels AB, et al. Cancer in patients on dialysis for
end-stage renal disease: an international collaborative study.
Lancet 1999; 354:93-9.
28. Kirkali Z, Lekili M. Renal cell carcinoma: new prognostic
factors? Curr Opin Urol 2003; 13:433-8.
29. Linehan WM, Walther MM, Zbar B. The genetic basis of
cancer of the kidney. J Urol 2003; 170(6 Pt 1): 2163-72.
30. Kiuru M, Kujala M, Aittomaki K. Inherited forms of renal cell
carcinoma. Scand J Surg 2004; 93:103-11.
31. Túrner KJ. Inherited renal cancer. BJU Int 2000; 86:1.
32. Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK,
Linehan WM, et al. von Hippel-Lindau disease. Lancet 2003;
361:2059-67.
33. Maher ER, Iselius L, Yates JR, Littler M, Benjamin C, Harris
R, et al. Von Hippel-Lindau disease: a genetic study. J Med
Genet 1991;28:443-7.
34. Eble JN, Sauter G, Epstein JI, Sesterhann IA, editors. World
Health Organization International Classifícation of Tumours.
Tumours of the urinary system and male genitial organs. IARC
Press, Lyon 2004.
35. Zbar B, Glenn G, Lubensky I, Choyke P, Walther MM,
Magnusson G, et al. Hereditary papillary renal cell carcinoma:
clinical studies in 10 families. J Urol 1995; 153 (3 Pt 2): 907-12.
36. Pavlovich CP, Walther MM, Eyler RA, Hewitt SM, Zbar B,
Linehan WM, et al. Renal tumors in the Birt-Hogg-Dube
syndrome. Am J Surg Pathol 2002; 26:1542-52.
37. Kim HL, Zisman A, Han KR, Figlin RA, Belldegrun AS.
Prognostic significance of venous thrombus in renal cell
carcinoma. Are renal vein and inferior vena cava involvement
different? J Urol 2004; 171(2 Pt 1): 588-91.
38. Ficarra V, Righetti R, D‘Amico A, Rubilotta E, Novella G,
Malossini G, et al. Renal vein and vena cava involvement
does not affect prognosis in patients with renal cell carcinoma.
Oncology 2001 ;61:10-5.
39. Ljungberg B, Landberg G, Alamdari FI. Factors of importance
for prediction of survival in patients with metastatic renal cell
carcinoma, treated with or without nephrectomy. Scand J Urol
Nephrol 2000; 34:246-51.
40. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS,
Delahunt B, et al. The Heidelberg classification of renal cell
tumours. J Pathol 1997; 183:131-3.
41. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML.
Comparisons of outcome and prognostic features among
histologic subtypes of renal cell carcinoma. Am J Surg Pathol
2003;27:612-24.
42. Beck SD, Patel MI, Snyder ME, Kattan MW, Motzer RJ,
Reuter VE, et al. Effect of papillary and chromophobe cell
type on disease-free survival after nephrectomy for renal cell
carcinoma. Ann Surg Oncol 2004; 11:71-7.
43. Ljungberg B, Alamdari FI, Stenling R, Roos G. Prognostic
significance of the Heidelberg classification of renal cell
carcinoma. Eur Urol 1999; 36:565-9.
44. Amin MB, Tamboli P, Javidan J, Stricker H, de-Peralta
Venturina M, Deshpande A, et al. Prognostic impact of
histologic subtyping of adult renal epithelial neoplasms: an
experience of 405 cases. Am J Surg Pathol 2002; 26:281 -91.
45. Zambrano NR, Lubensky IA, Merino MJ, Linehan WM,
Walther MM. Histopathology and molecular genetics of renal
tumors toward unification of a classification system. J Urol
1999; 162:1246-58.
46. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, et
al. Mutations of the VHL tumour suppressor gene in renal
carcinoma. Nat Genet 1994; 7:85-90.
47. Renshaw AA, Fletcher JA. Trisomy 3 in renal cell carcinoma.
Mod Pathol 1997;10:481-4.
48. Schwerdtle RF, Storkel S, Neuhaus C, Brauch H, Weidt E,
Brenner W, et al. Allelic losses at chromosomes lp, 2p, 6p, lOp,
13q, 17p, and 21q significantly correlate with the chromophobe
subtype of renal cell carcinoma. Cancer Res 1996; 56:2927-30.
49. Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick
DG, et al. Classification of renal cell carcinoma: Workgroup
No. 1. Union Internationale Contre le Cancer (UICC) and the
American Joint Committee on Cancer (AJCC). Cancer 1997;
80:987-9.
50. Amin MB, Crotty TB, Tickoo SK, Farrow GM. Renal
oncocytoma: a reappraisal of morphologic features with
clinicopathologic findings in 80 cases. Am J Surg Pathol 1997;
21:1-12.
51. Dechet CB, Bostwick DG, Blute ML, Bryant SC, Zincke H.
Renal oncocytoma: multifocality, bilateralism, metachronous
tumor development and coexistent renal cell carcinoma. J
Urol 1999; 162:40-2.
296 Læknablaðið 2007/93
1